MARKET ACCESS FOR PHARMACEUTICALS IN TÜRKİYE: A COMPREHENSIVE OVERVIEW

Authors : Ebru Erdağ, Selen Yeğenoğlu

Pages : 579-589

Doi:10.33483/jfpau.1601864

View : 209 | Download : 367

Publication Date : 2025-05-19

Article Type : Review Paper

Abstract :Objective: This study provides a detailed analysis of the market entry processes for pharmaceuticals in Türkiye, examining the key factors shaping these processes and their alignment with international standards. The aim is to highlight the significance of regulatory mechanisms, economic strategies, and health technology assessment (HTA) in ensuring patients\\\' access to high-quality medicines. Result and Discussion: The pharmaceutical sector in Türkiye has evolved into a dynamic and growing industry, supported by significant contributions from both domestic and international stakeholders. Regulatory advancements, such as the establishment of the Turkish Medicines and Medical Devices Agency (TİTCK), have improved licensing, pricing, and reimbursement processes, aligning them with international practices. Additionally, HTA has emerged as a critical tool in evidence-based decision-making, optimizing the efficient use of healthcare resources and supporting sustainable access to innovative treatments. However, to maintain their effectiveness, these processes require continuous updates and improvements. Such efforts will provide significant benefits not only to the industry but also to patients and society as a whole.
Keywords : Fiyatlandırma, geri ödeme, ilaç, pazara erişim, sağlık teknolojisi değerlendirmesi (STD)

ORIGINAL ARTICLE URL